Related Experiment Videos
Spinal cord involvement in systemic lupus erythematosus.
Paraplegia
|September 1, 1979
Summary
Systemic lupus erythematosus (SLE) can affect the central nervous system (CNS), particularly the spinal cord (lupus myelopathy). Early diagnosis and treatment with corticosteroids and immunosuppressants are crucial for managing CNS-SLE outcomes.
Area of Science:
- Neurology
- Rheumatology
- Immunology
Background:
- Systemic lupus erythematosus (SLE) is a chronic autoimmune disease with diverse clinical manifestations.
- Central nervous system involvement in SLE (CNS-SLE) presents a diagnostic and therapeutic challenge.
Observation:
- This review focuses on lupus myelopathy, a specific manifestation of CNS-SLE.
- Two illustrative cases highlight multisystemic involvement and varied clinical presentations.
- Analysis includes serum and cerebrospinal fluid (CSF) abnormalities, and histoimmunologic findings.
Findings:
- CNS-SLE exhibits a protean clinical pattern, making diagnosis difficult.
- Treatment response to corticosteroids and immunosuppressive agents is documented.
- Key prognostic features of CNS-SLE are identified.
Implications:
- Understanding CNS-SLE, especially lupus myelopathy, is vital for timely intervention.
- This review aids clinicians in diagnosing and managing neurological complications of SLE.
- Further research into prognostic factors can improve patient outcomes in CNS-SLE.